Status:

ACTIVE_NOT_RECRUITING

CORNEAL EPITHELIAL MAPPING IN DIABETICS

Lead Sponsor:

Minia University

Conditions:

Cornea Epithelial Mapping

Eligibility:

All Genders

40-70 years

Brief Summary

The corneal epithelium is the outermost layer that covers the front of the eye; it not only functions as a barrier that blocks the passage of foreign material, but also plays an important role in main...

Detailed Description

The cornea in diabetic patients suffers from cellular dysfunction and dysfunctional repairal mechanisms, which include recurrent erosions, delayed wound healing, ulcers, and edema. In addition and und...

Eligibility Criteria

Inclusion

  • The patients aged between 40- 60 years old of both genders.
  • The patients in (Group A) should be diabetics for more than 10 years and free from any other systemic diseases with diabetic macular edema (by OCT).
  • The patients in (Group B) should be diabetics for more than 10 years and free from any other systemic diseases without diabetic macular edema (by OCT).
  • The patients in (Group C) should be free of any systemic diseases and normal macular thickness (by OCT)

Exclusion

  • Previous history of any intraocular surgery, intravitreal injection, laser or refractive surgery.
  • Ocular surface disorders (e.g. dry eye) or any corneal pathology.
  • Corneal scars or epithelial dystrophies.
  • Use of any topical medications.
  • Elevated IOP, pregnancy or lactation.

Key Trial Info

Start Date :

August 12 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

153 Patients enrolled

Trial Details

Trial ID

NCT04734158

Start Date

August 12 2019

End Date

December 31 2025

Last Update

April 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Minia University

Minya, Egypt, 61111